|Articles|June 1, 2010

The latest innovations from Heidelberg Engineering at WOC Berlin

With BluePeak? - blue laser autofluorescence you can noninvasively view the health of the RPE, providing a functional map of RPEphotoreceptor metabolism. BluePeak is available for all SPECTRALIS models.

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Subscribe

Related Content

(Ophthalmology Times Europe) Lab bench to bedside to backpack: AI’s reach in retinal disease

AI's reach in retinal disease: Lab bench to bedside to backpack

BySheryl Stevenson

September 7th 2026

Visual training may ease neuroadaptation to presbyopia-correcting IOLs

ByDavid P. Piñero, PhD

September 5th 2026

When to retest for inherited retinal dystrophies

ByJoão Pedro Marques, MD, MSc, PhD,Sheryl Stevenson

Published: August 29th 2026 | Updated: August 29th 2026

Secondary IOL fixation: When to choose Yamane vs Gore-Tex

ByMatias Iglicki, MD, PhD,Sheryl Stevenson

August 23rd 2026

Effect of a maternal high-fat diet on the peripheral retina in mice

ByLynda Charters

August 12th 2026

Latest CME

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

The latest innovations from Heidelberg Engineering at WOC Berlin

Related Content

AI's reach in retinal disease: Lab bench to bedside to backpack

Visual training may ease neuroadaptation to presbyopia-correcting IOLs

When to retest for inherited retinal dystrophies

Secondary IOL fixation: When to choose Yamane vs Gore-Tex

Effect of a maternal high-fat diet on the peripheral retina in mice

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery